Koo, G., Stollings, J. L., Lindsell, C., Dear, M. L., Kripalani, S., Nelson, G. E., … Vanderbilt University Medical Center Learning Healthcare System. (2022). Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. J Allergy Clin Immunol Pract, 10(6), 1660-1663.e2. https://doi.org/10.1016/j.jaip.2022.01.041

Koo, Grace, Joanna L. Stollings, Christopher Lindsell, Mary Lynn Dear, Sunil Kripalani, George E. Nelson, Allison B. McCoy, et al. “Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.” J Allergy Clin Immunol Pract 10, no. 6 (June 2022): 1660-1663.e2. https://doi.org/10.1016/j.jaip.2022.01.041.

Koo G, Stollings JL, Lindsell C, Dear ML, Kripalani S, Nelson GE, et al. Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. J Allergy Clin Immunol Pract. 2022 Jun;10(6):1660-1663.e2.

Koo, Grace, et al. “Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.” J Allergy Clin Immunol Pract, vol. 10, no. 6, June 2022, pp. 1660-1663.e2. Pubmed, doi:10.1016/j.jaip.2022.01.041.

Koo G, Stollings JL, Lindsell C, Dear ML, Kripalani S, Nelson GE, McCoy AB, Rice TW, Phillips EJ, Stone CA, Vanderbilt University Medical Center Learning Healthcare System. Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. J Allergy Clin Immunol Pract. 2022 Jun;10(6):1660-1663.e2.